56 results on '"Kakkar V"'
Search Results
2. PROTEIN C/PROTEIN S IN THE FOETAL BLOOD. ABSENCE OF BOUND PROTEINS AND C4 BINDING PROTEIN
3. CIRCADIAN CHANGES IN THE ANTICOAGULANT EFFECT OF HEPARIN. PHARMACODYNAMIC AND PHARMACOKINETIC EFFECT
4. R59022, A DIACYLGLYCEROL (DG) KINASE INHIBITOR POTENTIATES THROMBIN-INDUCED PLATELET AGGREGATION AND GRANULE RELEASE
5. A TRIAL OF SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF LOW MOLECULAR WEIGHT (LMW) HEPARIN AND UNFRACTIONATED (UF) HEPARIN IN THE TREATMENT OF ESTABLISHED DEEP VENOUS THROMBOSIS (DVT)
6. Prostanoids And Endotoxaemia In The Mini-Pig
7. In Vitro Studies on Thrombolysis with Plasminogen and Streptokinase
8. Low-Dose Heparin Prophylaxis Against Fatal Pulmonary Embolism
9. Inhibition Of Human Factor Xa By Various Plasma Protease Inhibitors
10. Heparin and Factor XaI Levels in Patients Undergoing Hip Surgery
11. Objective Assessment Of Late Results Of Treatment Of Deep Vein Thrombosis
12. ARE THE SYMPTOMS OF THE POST PHLEBITIC LIMB ALWAYS POST THROMBOTIC
13. CONGENITAL SEVERE PROTEIN C DEFICIENCY IN ADULTS
14. INCREASED UPTAKE OF MONOCYTE-TREATED LOW-DENSITY LIPOPROTEINS BY AORTIC ENDOTHELIUM IN VIVO
15. A DOSE RANGING STUDY DESIGNED TO ASSESS THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN FRAGMENT (FRAGMIN) AS PROPHYLAXIS AGAINST DEEP VEIN THROMBOSIS
16. Low Molecular Weight Heparin And Postoperative Deep Vein Thrombosis
17. Viscosity and Red Cell Deformity in Arterial Disease
18. Characterisation of a Soluble High Molecular Weight e Fragment Released by Plasmin from Cross-linked Fibrin
19. Intermittent Infusions Of Arvin And Low-Dose Urokinase In The Treatment Of Deep Vein Thrombosis
20. Inhibition Of Contact Activation By Platelet Factor 4
21. EFFECT OF PROTEIN KINASE C (PrkC) ACTIVATORS ON AGONIST-INDUCED ARACHIDONATE RELEASE IN HUMAN PLATELETS
22. MEASUREMENT OF HEPARIN IN PLASMA: INFLUENCE OF INTER-SUBJECT AND CIRCADIAN VARIABILITY IN HEPARIN SENSITIVITY ACCORDING TO METHOD
23. EXOGENOUSLY ADDED DIACYLGLYCEROL (DAG) AND ELEVATED INTRACELLULAR Ca2+ LEVELS CANNOT SUBSTITUTE FOR PROSTAGLANDIN END0PER0XIDES/ THROMBOXANE ki IN MEDIATING WEAK AGONIST-INDUCED PLATELET SECRETION
24. 1,2-DIOCTANOYLGLYCERIOL (diC8) BUT NOT 1-OLEOYL 2-ACETYLGLYCEROL (OAG) INHIBITS AGONIST-INDUCED PLATELET RESPONSES
25. Amine Inhibition of Fibrin Cross-Linking
26. Adenosine 3‘,5‘-Cyclic Monophosphate (C-AMP) And Inhibitors Of Platelet Aggregation: A Possibility Of A Double C-AMP Pool In Human Platelets
27. A Comparative Study of the Effects of Heparin and a Low Molecular Weight Semi-Synthetic Heparin Analogue Upon Platelet Function
28. Antithrombin III Infusion During Fulminant Hepatic Failure
29. An Experimental Model for the Study of Venous Thrombosis in Vivo
30. Differential Stability Of Prostacyclin (PGI2) In Whole Blood And Plasma
31. ADRENALINE (ADR) INTERACTIONS WITH THROMBIN AND COLLAGEN -EFFECTS ON PLATELET ARACHIDONATE RELEASE AND 5HT SECRETION AND ROLE OF ENDOGENOUSLY FORMED THROMBOXANE A2 (TxA2)
32. Fibrinogen Degradation in Normal and Fibrinolytic Plasma
33. PLASMINOGEN ACTIVATION BY SINGLE-CHAIN UROKINASE (scu-PA) IN FUNCTIONAL ISOLATION - DEMONSTRATION OF A NOVEL MECHANISM
34. Evaluation Of In Vivo Platelet Activation In Sickle Cell Disease
35. GENERATION OF REACTIVE OXYGEN METABOLITES BY PHAGOCYTOSING ENDOTHELIAL CELLS: REGULATORY ROLE OF THE GLYCOCALYX
36. An Acquired Inhibitor To Coagulation Factor II
37. Endotoxin Induced Fall In Plasma Prekallikrein: Prevention By Prostacyclin And Lignocained
38. PLASMA FREE PROTEIN S AND OESTROGEN ADMINISTRATION
39. KINETICS OF HEPARIN CO-FACTOR II (HCII):THROMBIN AND ANTITHROMBIN III (ATIII):THROMBIN INTERACTION. MOLECULAR WEIGHT DEPENDENCY
40. Single Oral Dose Administration Of A Specific Thromboxane Synthetase Inhibitor To Normal Volunteers - A Double Blind Placebo Controlled Study
41. THROMBIN BINDING FRAGMENT E GENERATED DURING FIBRINOGENOLYSIS
42. Zinc Chelate Chromatography Of Fibrinogen
43. Thrombocytopaenia, Thromboxane And Prostacyclin Production During The Forssman Reaction In The Guinea-Pig: Effect Of A Thromboxane Synthetase Inhibitor
44. Possible Mode Of Action Of A Semi-Synthetic Heparin Analogue . (SSHA)
45. Endotoxin Inhibits Prostacyclin Release From Rabbit Aorta
46. Studies on Fractionated Heparin
47. Treatment Of Venous Thromboembolism - Case For Thrombolytic Therapy
48. Fatal Pulmonary Embolism and Surgery
49. DOES LOW-DOSE PERI-OPERATIVE HEPARIN ADMINISTRATION AFFECT MORTALITY FOLLOWING MAJOR ABDOMINAL SURGERY?
50. The Kinetics of Clearance from the Circulation of Man of Heparin and a Semi-Synthetic Heparin Analogue
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.